tiprankstipranks
Trending News
More News >
Regulus Therapeutics Inc (RGLS)
:RGLS
US Market

Regulus (RGLS) Income Statement

Compare
886 Followers

Regulus Income Statement

Last quarter (Q4 2024), Regulus's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Regulus's net income was $-12.79M. See Regulus’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 10.01M
Gross Profit
$ 0.00$ -21.15M$ -122.00K$ -459.00K$ 9.99M
Operating Expenses
$ 50.04M$ 9.96M$ 28.24M$ 27.82M$ 24.16M
Depreciation and Amortization
$ 347.00K$ 227.00K$ 122.00K$ 459.00K$ 467.00K
EBITDA
$ -45.85M$ -30.88M$ -28.12M$ -27.36M$ -13.46M
Operating Income
$ -50.04M$ -31.11M$ -28.24M$ -27.82M$ -14.15M
Other Income/Expenses
$ 3.68M$ 1.07M$ -83.00K$ 9.00K$ -1.57M
Pretax Income
$ -46.36M$ -30.04M$ -28.32M$ -27.81M$ -15.73M
Net Income
$ -46.36M$ -30.04M$ -28.32M$ -27.81M$ -15.26M
Per Share Metrics
Basic EPS
$ -0.82$ -1.58$ -1.86$ -3.24$ -4.36
Diluted EPS
$ -0.82$ -1.58$ -1.86$ -3.24$ -4.36
Weighted Average Shares Outstanding
56.35M 18.96M 15.26M 8.57M 3.50M
Weighted Average Shares Outstanding (Diluted)
56.35M 18.96M 15.26M 8.57M 3.50M
Currency in USD

Regulus Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis